Magungunan asarar nauyi Belviq ya janye daga kasuwar Amurka yayin da yake damuwa yana haifar da haɗarin cutar kansa
Belviq - magani mai rage nauyi - an cire shi daga kasuwar Amurka saboda buƙatar janyewar kasuwar FDA. Bayanai sun nuna yawan haɗarin cutar kansa idan aka kwatanta da placebo.
FDA ta amince da farko tsarin Eliquis: apixaban
Waɗanda ke cikin haɗarin bugun jini nan ba da daɗewa ba za su sami arha mai sauƙi ga Eliquis, mai siririn jini. FDA ta amince da nau'ikan 2 na jigilar Eliquis (apixaban) a watan Disamba na 2019.
FDA ta amince da Erleada, sabon maganin cutar kansar mafitsara
Erleada ita ce magani ta farko da aka yarda da FDA don ƙwayoyin cuta masu saurin jurewa, ba sa yaɗuwa (ciwan da ba ta metastatic ba) wanda ya zo a matsayin maraba da maraba ga marasa lafiya da ke da cutar sankarar mahaifa.
FDA ta amince da Ervebo, allurar rigakafin cutar Ebola ta farko
Ervebo, allurar rigakafin kwayar cutar Ebola ta farko a duniya ta nuna alamar lafiyar jama'a don karewa daga wannan cuta mai saurin yaduwa.
Duk abin da muka sani game da Favilavir, yiwuwar maganin coronavirus
Favilavir magani ne na rigakafin cutar wanda ake amfani dashi azaman maganin mura a cikin Japan kuma yanzu yana fuskantar gwaji na asibiti akan COVID-19 a China.
FDA ta amince da yanayin Gilenya
A ranar 5 ga Disamba, 2019 Hukumar Abinci da Magunguna ta Amurka (FDA) ta ba da sanarwar amincewa da fingolimod, nau'ikan nau'ikan Gilenya, magani ne da ke kula da MS.
9 nau'ikan nau'ikan sihiri na Lyrica yanzu ana samunsu akan farashi mai sauki ga marasa lafiya
FDA ta amince da nau'ikan 9 na Lyrica generic (pregabalin) don rage farashinta. Mai hana yaduwar cutar zai iya kashe $ 320- $ 350 kasa da sunan-mai suna Lyrica.
FDA ta amince da magani na farko na baka don zubar jini mai nauyi daga mahaifa
Ba da daɗewa ba za a sami magani na baka don sauƙaƙe zubar jini mai nauyi (menorrhagia) daga ɓarkewar mahaifa, godiya ga FDA-amincewar Oriahnn.
FDA ta tuno da metformin wanda aka sake shi
A watan Mayu 2020, FDA ta ba da sanarwar tunatar da kai don allunan metformin ER 500 mg. Ranar 4 ga Janairu, 2021, an sake faɗakar da ambaton.
Koyi game da sababbin magunguna 5 da ke zuwa a cikin 2020
FDA ta amince da sababbin magunguna kowace shekara. Wasu sun zo daidai kasuwa, yayin da wasu suka jinkirta. Waɗannan sune mafiya ban sha'awa akan hanya.
Sababbin magunguna na yau da kullun a cikin 2019
Magunguna arba'in sun zama wadatar su azaman kwayar halitta a cikin 2019. Duba yadda waɗannan sababbin magungunan kwayoyi suke kwatankwacin takwarorinsu na alama.
FDA ta cire duk nau'ikan ranitidine daga kasuwar Amurka
Shin kai mai amfani ne da Zantac ko kuma tsarinta? Koyi abin da wannan ke nufi a gare ku yayin da shagunan sayar da magani suka daina bayar da kwayoyin saboda tunawar ranitidine.
FDA ta amince da Qelbree, wani sabon magani na ADHD wanda ba shi da kuzari
Qelbree (viloxazine), sabon magani na farko wanda bashi da kuzari don ADHD a cikin shekaru 10, zai wadatar da marasa lafiya a zango na biyu na 2021.
FDA ta amince da sauyawar Rx-to-OTC don maganin ƙoshin kai
Wannan maganin shafawa na kai kawai, Sklice, yanzu ana samunsa a kan-kan-kan.
